Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis
Open Access
- 1 June 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 85 (6) , 818-825
- https://doi.org/10.1046/j.1365-2168.1998.00710.x
Abstract
Background: Severe intra-abdominal sepsis continues to carry a high mortality rate. The physiological response to sepsis in this condition and its relationship with proinflammatory mediators and their endogenous antagonists require further clarification. Methods: Fifty-seven patients were stratified by Acute Physiology And Chronic Health Evaluation (APACHE) II score at the time of admission to an intensive care unit (group 1, score of less than 20; group 2, score of 20 or more). Serial measurements of clinical and immunological variables were made. Results: Non-survivors from group 2 had a raised acute physiology score (P = 0·01), a higher peak serum interleukin (IL) 6 concentration (P = 0·03) and a depressed level of endogenous immunoglobulin (Ig) G class antiendotoxin core antibody (P = 0·005). In group 1, although organ failure score increased progressively in non-survivors, physiology score and peak IL-6 level were similar to those in survivors, and endogenous IgG class antiendotoxin core antibody titre rose (P = 0·02). In both groups IL-1 and tumour necrosis factor α were detected infrequently, but their natural antagonists were present in much higher concentrations in both survivors and non-survivors. Levels of C-reactive protein were raised in both but were not significantly different between survivors and non-survivors. Conclusion: During the development of organ failure and death, the pattern of proinflammatory mediators and their endogenous antagonists can vary markedly and may in part be determined by the extent of the initial physiological disturbance.Keywords
This publication has 34 references indexed in Scilit:
- Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndromeCritical Care Medicine, 1994
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infectionWorld Journal of Surgery, 1990
- Intraabdominal infections—IntroductionWorld Journal of Surgery, 1990
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual DifferencesScandinavian Journal of Immunology, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- APACHE IICritical Care Medicine, 1985
- Re-operation for Intra-abdominal SepsisAnnals of Surgery, 1984